Keynote Speakers

  Wilson Compton, MD, MPE
Deputy Director, National Institute on Drug Abuse, National Insitutes of Health
 
  Wilson Compton

Wilson M. Compton, MD, MPE is Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health, where he provides scientific leadership in the development, implementation, and management of NIDA’s research portfolio and works with the Director to support and conduct research.
From 2002-2013, Dr. Compton served as the Director of NIDA’s Division of Epidemiology, Services and Prevention Research, overseeing the scientific direction of a complex public health research program addressing the extent, spread, and prevention of drug abuse, and implementing effective prevention and treatment services. Prior to that, Dr. Compton was Associate Professor of Psychiatry and Director of the Master in Psychiatric Epidemiology Program at Washington University as well as Medical Director of Addiction Services at the Barnes-Jewish Hospital in Saint Louis.
Honors received by Dr. Compton include the Scholar Health Services Research Award, the Paul Hoch Award, the Leveraging Collaboration Award from the Food and Drug Administration, and the Health and Human Services Secretary’s Awards for Meritorious Service (2013) and Distinguished Service (2014).

 
     
 

John M. Kane, MD
Professor and Chairman, Department of Psychiatry, Hofstra Northwell School of Medicine

 
  John Kane

John M. Kane, MD, is Senior Vice President for Behavioral Health Services at Northwell Health in New Hyde Park, New York and Chairman of the Department of Psychiatry at The Zucker Hillside Hospital in Glen Oaks, New York. Additionally, he is Professor and Chairman of Psychiatry at The Hofstra Northwell School of Medicine. He is a Diplomate of the American Board of Psychiatry and Neurology.
Awards received by Dr. Kane include the Lieber Prize, the APA Kempf Award and Foundations Prize, the New York State Office of Mental Health Lifetime Achievement Award, and The Dean Award from the American College of Psychiatrists. He has served as President of the American Society of Clinical Psychopharmacology, the Psychiatry Research Society and the Schizophrenia International Research Society. Dr. Kane has been the principal investigator for research projects focusing on schizophrenia, psychobiolgy and treatment, recovery, and improving quality and cost of care.

 
   
  Pierre N. Tariot, MD
Director, Banner Alzheimer's Institute; Research Professor of Psychiatry, University of Arizona College of Medicine
 
  Pierre Tariot

Dr. Pierre Tariot, director of Banner Alzheimer’s Institute, is board-certified in internal medicine and geriatric psychiatry. He received intensive training in developing new treatments for Alzheimer's disease at the National Institutes of Health. He spent 20 years as a professor at the University of Rochester Medical Center in New York, directing a program dedicated to the care and study of those with Alzheimer's. In 2006, he joined Dr. Eric Reiman to launch Banner Alzheimer's Institute and serve as a research professor at the University of Arizona College of Medicine.
Dr. Tariot is a fellow of the Gerontological Society of America, distinguished fellow of the American Psychiatric Association and member of the American College of Neuropsychopharmacology, as well as a past chair of the Behavioral Pathology Committee of the National Institute on Aging's Consortium to Establish a Registry for Alzheimer's Disease.
Dr. Tariot has devoted his career to helping patients and families cope with the effects of dementia and is a leader in the development of new Alzheimer's treatments. He has published hundreds of scientific articles, is a respected speaker and consultant, and has won numerous awards for his service and research.

 

 

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.